Disease modification in osteoarthritis; pathways to drug approval

Katz, JN, Neogi, T, Callahan, LF et al. (5 more authors) (2020) Disease modification in osteoarthritis; pathways to drug approval. Osteoarthritis and Cartilage Open, 2 (2). 100059. ISSN 2665-9131



Copyright, Publisher and Additional Information: © 2020 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International (OARSI). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Osteoarthritis; Structure-modifying therapy; Regulatory approval
  • Accepted: 2 March 2020
  • Published (online): 10 March 2020
  • Published: June 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Mar 2020 16:18
Last Modified: 18 May 2023 10:53
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ocarto.2020.100059

Share / Export